Covered recipient · General Payments record
BETHANY NUNN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$713.29
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $339.32 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $157.57 | 6 |
| SCILEX PHARMACEUTICALS INC. | $51.86 | 3 |
| Lundbeck LLC | $37.87 | 2 |
| Abbott Laboratories | $24.44 | 1 |
| Valinor Pharma, LLC | $19.55 | 1 |
| IMPEL PHARMACEUTICALS INC. | $18.00 | 1 |
| Kowa Pharmaceuticals America, Inc. | $16.05 | 1 |
| ABBVIE INC. | $13.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.44 | 03/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019764545 | CMS |
| ABBVIE INC. | $13.98 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1008943321 | CMS |
| IMPEL PHARMACEUTICALS INC. | $18.00 | 07/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989455323 | CMS |
| Kowa Pharmaceuticals America, Inc. | $16.05 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003919393 | CMS |
| Lundbeck LLC | $24.35 | 07/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032638713 | CMS |
| Lundbeck LLC | $13.52 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032638719 | CMS |
| Medtronic, Inc. | $6.81 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019677926 | CMS |
| Medtronic, Inc. | $6.10 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019677921 | CMS |
| Medtronic, Inc. | $6.89 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019677931 | CMS |
| Medtronic, Inc. | $5.85 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019677939 | CMS |
| Medtronic, Inc. | $5.85 | 10/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019677945 | CMS |
| Medtronic, Inc. | $126.07 | 12/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019677949 | CMS |
| Scilex Pharmaceuticals Inc. | $18.18 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045436545 | CMS |
| Scilex Pharmaceuticals Inc. | $17.93 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045479669 | CMS |
| Scilex Pharmaceuticals Inc. | $15.75 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045488069 | CMS |
| Valinor Pharma, LLC | $19.55 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054191057 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.